ARCHIVES

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: ACCC Celebrates 25th: James Hospital Receives Large Donations

April 9, 1999

FDA Approves Ribavirin Phase 102 Trials

October 30, 1987

In Appropriations Hearings, Groups Seek NCI Bypass Budget, Differ On CDC Funding.

April 7, 2000

NCI FY94 Budget By Mechanism Under House, Senate Mark

September 24, 1993

NCI Producing TV Tapes For Black Awareness Program

March 14, 1986

Avastin Improves Survival By 30 Percent In Advanced Non-Small Cell Lung Cancer

June 24, 2005